Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial-Reference-Cited by-同舟云学术

Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial

Published:2023-02 Issue: Volume:26 Page:100264
ISSN:2666-6022
Container-title:American Heart Journal Plus: Cardiology Research and Practice
language:en
Short-container-title:American Heart Journal Plus: Cardiology Research and Practice

Author:

Larsen Julie Hempel,Omar Massar,Jensen Jesper,Andersen Camilla Fuchs,Kistrup Caroline Michaela,Poulsen Mikael Kjær,Videbæk Lars,Gustafsson Finn,Køber Lars,Schou Morten,Møller Jacob Eifer

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling;Cohn;J. Am. Coll. Cardiol.,2000

2. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment;Konstam;JACC Cardiovasc. Imaging,2011

3. Prognostic significance of echocardiographic measures of cardiac remodeling;von Jeinsen;J. Am. Soc. Echocardiogr.,2020

4. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction;Udelson;Circ Heart Fail.,2010

5. Cardiac remodelling - part 2: clinical, imaging and laboratory findings. A review from the study group on biomarkers of the heart failure Association of the European Society of cardiology;Aimo;Eur. J. Heart Fail.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left ventricular reverse remodeling after combined ARNI and SGLT2 therapy in heart failure patients with reduced or mildly reduced ejection fraction;IJC Heart & Vasculature;2024-10

2. Benefits of sacubitril/valsartan administration and physical training in cardiac rehabilitation: current trends and bibliometric analysis of the years 2015-2024;Balneo and PRM Research Journal;2024-06-21

3. Efficacy of sacubitril‐valsartan and SGLT2 inhibitors in heart failure with reduced ejection fraction: A systematic review and meta‐analysis;Clinical Cardiology;2023-07-19